XM does not provide services to residents of the United States of America.
E
E

ElectronicArts

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Armada Hoffler Properties, Morphic Holding, Solid Biosciences

U.S. RESEARCH ROUNDUP-Armada Hoffler Properties, Morphic Holding, Solid Biosciences July 15 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Armada Hoffler Properties, Morphic Holding and Solid Biosciences, on Monday. HIGHLIGHTS * Armada Hoffler Properties Inc AHH.N : Jefferies cuts to hold from buy * Morphic Holding Inc MORF.O : Jefferies cuts to hold from buy * Solid Biosciences Inc SLDB.O : JP Morgan raises to over
A
A
C
C
H
J
A
E
P
U
W
A
E
H
M

Jefferies sees video game industry bouncing back to growth in 2025

BUZZ-Jefferies sees video game industry bouncing back to growth in 2025 ** Jefferies sees FY25, FY26 as new high watermarks for the video game industry, returning to growth through a mix of new content, evolving business models and new platforms ** Brokerage initiates Electronic Arts EA.O with "buy" and PT of $165 ** Says, EA unrivaled in sports an
E
T

U.S. CoreCivic, Eli Lilly, 40

U.S. RESEARCH ROUNDUP-CoreCivic, Eli Lilly, WD-40 July 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CoreCivic , Eli Lilly and WD -40, on Thursday. HIGHLIGHTS * Antero Resources Corp AR.N : Gerdes Energy Research raises to buy from neutral * CoreCivic Inc CXW.N : Jonestrading initiates coverage with hold rating * Costco Wholesale Corp COST.O : Jefferies raises target price to $1050 from $860 * Eli Lilly LLY.N :
C
F
E
E
E
I
D

EQT’s $3 bln gaming play hits the right buttons

BREAKINGVIEWS-EQT’s $3 bln gaming play hits the right buttons The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Oliver Taslic LONDON, July 3 (Reuters Breakingviews) - EQT EQTAB.ST has found a solid strategy for investing in the unreliable gaming market. The Swedish buyout shop is splurging 2.1 billion pounds on Keywords Studios KWS.L , a business that services game designers like Nintendo 7974.T .
C
E
T

U.S. CarMax, Eli Lilly, MicroStrategy

U.S. RESEARCH ROUNDUP-CarMax, Eli Lilly, MicroStrategy June 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CarMax, Eli Lilly and MicroStrategy, on Monday. HIGHLIGHTS * CarMax Inc KMX.N : RBC raises target price to $75 from $73 * Eli Lilly LLY.N : Jefferies raises target price to $1,015 from $994 * MicroStrategy Inc MSTR.O : Canaccord Genuity cuts target price to $1,826 from $2,047 * Sharecare Inc SHCR.O : Canacco
A
A
B
D
G
M
N
V
E
F
T
E
P
R
T
C
C
I

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.